Macrophage Differentiation via Pressurized Environment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack a technique for selectively differentiating macrophages into M1 macrophages, which are crucial for anticancer and anti-inflammation responses, while existing techniques focus on differentiating into M2 macrophages.
Innovation Solution
A method involving the incubation of undifferentiated macrophages in a pressurized environment using a transwell or pressurized air, with an alginate hydrogel, to selectively differentiate them into M1 macrophages, and subsequently into osteoclasts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional anticancer therapy methods (surgery, chemotherapy, radiotherapy) are used, then cancer treatment is achieved, but immunity decreases in the long term and side effects occur
Solution Approach 1:
The patent replaces traditional mechanical/chemical anticancer therapies (surgery, chemotherapy, radiotherapy) with a biological mechanism-based approach using pressurized differentiation of macrophages into M1 type. This substitution uses cellular differentiation controlled by pressure as a new mechanism to achieve anticancer effects without the harmful side effects of conventional therapies.
Solution Approach 2:
The patent changes the physical parameter of pressure to control macrophage differentiation. By applying specific pressure conditions during cell culture, undifferentiated macrophages are directed to differentiate into M1 macrophages, which have potent anticancer and anti-inflammatory properties. This parameter change provides a new control mechanism that avoids the toxicity of chemical therapies.
2Ease of manufacture
If existing macrophage differentiation techniques are used, then M2 macrophages are produced, but M1 macrophages which are crucial for anticancer responses cannot be obtained
Solution Approach 1:
Instead of using chemical or biological factors that typically drive macrophage differentiation (as in conventional M2 differentiation methods), the patent inverts the approach by using mechanical pressure as the differentiating factor. This inverted methodology enables M1 macrophage production, which is the opposite outcome of traditional differentiation protocols.
Solution Approach 2:
The patent changes the differentiation parameter from chemical/biological factors to physical pressure. This parameter change enables selective production of M1 macrophages, overcoming the limitation of existing techniques that can only produce M2 macrophages through conventional differentiation factors.
Data Source
AI summary
Provided is a method for the selective differentiation into M1 macrophages under a pressurized environment, and more particularly, a method for the selective differentiation of undifferentiated macrophages into M1 macrophages, the method including incubating the undifferentiated macrophages in an incubator under the pressurized environment. In addition, provided is a method for producing osteoclasts, the method including: incubating undifferentiated macrophages in an incubator under a pressurized environment to differentiate into M1 macrophages; and differentiating the differentiated M1 macrophages into osteoclasts.